The company is an international biopharmaceutical company with a strategic focus on skin health. The company has 15 branches in Europe and the USA.
After Keil was already allowed to construct the new solvent tank farm at the site in Reinbek in 2019, further pipelines for ethanol and ethyl acetate distribution will now be assembled, including the electrical engineering and automation of the new plant components.
Completion is planned for the end of 2023.